Biofrontera AG buy melinda
Start price
05.03.18
/
50%
€5.95
Target price
09.03.18
€6.40
Performance (%)
8.07%
End price
09.03.18
€6.43
Summary
This prediction ended on 09.03.18 with a price of €6.43. With a performance of 8.07%, the BUY prediction by melinda for Biofrontera AG closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% | 68.731% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% | 113.533% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% | 50.934% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% | 68.205% |
According to melinda what are the pros and cons of Biofrontera AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Biofrontera AG diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Kalender 11/07 Generalversammlung
Biofrontera: Die Europäische Kommission genehmigt die Verwendung von Ameluz in Kombination mit der photodynamischen Therapie Tageslicht
5. März (Reuters) - Die Biofrontera AG :: PTA-ADHOC: Biofrontera AG: DIE EUROPÄISCHE KOMMISSION GENEHMIGT DEN EINSATZ IN KOMBINATION MIT Ameluz THERAPY Photodynamischen den Tag.
Stopped prediction by melinda for Biofrontera AG
Biofrontera AG
Start price
Target price
Perf. (%)
€1.60
06.12.21
06.12.21
€2.80
06.12.22
06.12.22
-1.25%
07.12.22
07.12.22
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€3.16
17.03.20
17.03.20
€6.00
04.11.21
04.11.21
-25.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€6.29
09.03.18
09.03.18
€8.00
14.03.18
14.03.18
13.99%
14.03.18
14.03.18
Could be worthwhile Investment >10% per year